Added to YB: 2024-08-07
Pitch date: 2024-08-06
ILMN [bullish]
Illumina, Inc.
+0.16%
current return
Author Info
Catalyst Seeker shares ideas and notes on event-driven ideas and special situations. Sign up for the newsletter.
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$17.9B
Pitch Price
$119.81
Price Target
183.00 (+53%)
Dividend
N/A
EV/EBITDA
15.33
P/E
21.43
EV/Sales
4.32
Sector
Life Sciences Tools and Services
Category
special_situation
Illumina (ILMN US) Catalyst Idea - Value + Catalyst
ILMN: $183 PT, 56% upside. Core biz undervalued due to GRAIL distraction. 80% NGS market share, strong ecosystem. Clinical market growth (18% CAGR 2023-26), new NovaSeq X driving consumables. Cost cuts: SG&A $175M saved, R&D to 10% of rev. Spin-off catalyst for re-rating. Risks: competition, MCED regulatory hurdles. 2.93x risk/reward at $110.
Read full article (11 min)